| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442637 | European Journal of Cancer | 2015 | 9 Pages |
Abstract
Tumour-expressing HVEM plays a critical role in human HCC, possibly through regulating immune evasion. Therefore, targeting HVEM may be a novel promising therapeutic strategy for HCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Daisuke Hokuto, Masayuki Sho, Ichiro Yamato, Satoshi Yasuda, Shinsaku Obara, Takeo Nomi, Yoshiyuki Nakajima,